Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab ...
An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...
University of Brighton researchers are spearheading a national effort to create a pioneering diagnostic tool that can ...
UAE influencer Khalid Al Ameri has officially confirmed his relationship with the South Indian actress Sunainaa Yella. The ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results